Restatorvid (TAK-242), another TLR4-targeted inhibitor, significantly reduced the infarct size and edema degree after cerebral ischemia and hypoxia in rats in an in vivo study (Jiang et al., 2020). Here, TLR4 is linked to Cerebral ischemia.